The impact of European harmonisation on Norwegian drug policy
No abstract is available for this item.
Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile, click on "citations" and make appropriate adjustments.:
- Andersson, Fredrik, 1992. "Norway's pivotal role in regulatory health economics and pharmaceutical cost containment - what can other countries learn?," Health Policy, Elsevier, vol. 21(1), pages 17-34, May.
When requesting a correction, please mention this item's handle: RePEc:eee:hepoli:v:43:y:1998:i:1:p:65-81. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Dana Niculescu)or ()
If references are entirely missing, you can add them using this form.